35620289|t|Protective Signature of IFNgamma-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells.
35620289|a|Microglia-associated inflammation and miRNA dysregulation are key players in Alzheimer's disease (AD) pathophysiology. Previously, we showed miR-124 upregulation in APP Swedish SH-SY5Y (SWE) and PSEN1 iPSC-derived neurons and its propagation by the secretome (soluble and exosomal fractions). After modulation with miR-124 mimic/inhibitor, we identified common responsive mechanisms between such models. We also reported miR-124 colocalization with microglia in AD patient hippocampi. Herein, we determined how miR-124 modulation in SWE cells influences microglia polarized subtypes in the context of inflammation. We used a coculture system without cell-to-cell contact formed by miR-124 modulated SWE cells and human CHME3 microglia stimulated with interferon-gamma (IFNgamma-MG), in which we assessed their adopted gene/miRNA profile and proteomic signature. The increase of miR-124 in SWE cells/secretome (soluble and exosomal) was mimicked in IFNgamma-MG. Treatment of SWE cells with the miR-124 inhibitor led to RAGE overexpression and loss of neuronal viability, while the mimic caused RAGE/HMGB1 downregulation and prevented mitochondria membrane potential loss. When accessing the paracrine effects on microglia, SWE miR-124 inhibitor favored their IFNgamma-induced inflammatory signature (upregulated RAGE/HMGB1/iNOS/IL-1beta; downregulated IL-10/ARG-1), while the mimic reduced microglia activation (downregulated TNF-alpha/iNOS) and deactivated extracellular MMP-2/MMP-9 levels. Microglia proteomics identified 113 responsive proteins to SWE miR-124 levels, including a subgroup of 17 proteins involved in immune function/inflammation and/or miR-124 targets. A total of 72 proteins were downregulated (e.g., MAP2K6) and 21 upregulated (e.g., PAWR) by the mimic, while the inhibitor also upregulated 21 proteins and downregulated 17 (e.g., TGFB1, PAWR, and EFEMP1). Other targets were associated with neurodevelopmental mechanisms, synaptic function, and vesicular trafficking. To examine the source of miR-124 variations in microglia, we silenced the RNase III endonuclease Dicer1 to block miRNA canonical biogenesis. Despite this suppression, the coculture with SWE cells/exosomes still raised microglial miR-124 levels, evidencing miR-124 transfer from neurons to microglia. This study is pioneer in elucidating that neuronal miR-124 reshapes microglia plasticity and in revealing the relevance of neuronal survival in mechanisms underlying inflammation in AD-associated neurodegeneration. These novel insights pave the way for the application of miRNA-based neuropharmacological strategies in AD whenever miRNA dysregulated levels are identified during patient stratification.
35620289	24	32	IFNgamma	Gene	3458
35620289	44	53	Microglia	Disease	
35620289	64	74	miR-124-3p	Gene	406909
35620289	152	161	Microglia	Disease	
35620289	173	185	inflammation	Disease	MESH:D007249
35620289	229	248	Alzheimer's disease	Disease	MESH:D000544
35620289	250	252	AD	Disease	MESH:D000544
35620289	329	336	SH-SY5Y	CellLine	CVCL:0019
35620289	338	341	SWE	CellLine	CVCL:0019
35620289	347	352	PSEN1	CellLine	CVCL:TH26
35620289	601	610	microglia	Disease	
35620289	614	616	AD	Disease	MESH:D000544
35620289	617	624	patient	Species	9606
35620289	685	688	SWE	CellLine	CVCL:0019
35620289	706	715	microglia	Disease	
35620289	753	765	inflammation	Disease	MESH:D007249
35620289	851	854	SWE	CellLine	CVCL:0019
35620289	865	870	human	Species	9606
35620289	871	876	CHME3	CellLine	CVCL:II76
35620289	877	886	microglia	Disease	
35620289	903	919	interferon-gamma	Gene	3458
35620289	921	929	IFNgamma	Gene	3458
35620289	1041	1044	SWE	CellLine	CVCL:0019
35620289	1100	1108	IFNgamma	Gene	3458
35620289	1126	1129	SWE	CellLine	CVCL:0019
35620289	1170	1174	RAGE	Gene	177
35620289	1245	1249	RAGE	Gene	177
35620289	1250	1255	HMGB1	Gene	3146
35620289	1363	1372	microglia	Disease	
35620289	1374	1377	SWE	CellLine	CVCL:0019
35620289	1410	1418	IFNgamma	Gene	3458
35620289	1427	1439	inflammatory	Disease	MESH:D007249
35620289	1463	1467	RAGE	Gene	177
35620289	1468	1473	HMGB1	Gene	3146
35620289	1474	1478	iNOS	Gene	51477
35620289	1479	1487	IL-1beta	Gene	3553
35620289	1503	1508	IL-10	Gene	3586
35620289	1509	1514	ARG-1	Gene	383
35620289	1541	1550	microglia	Disease	
35620289	1577	1586	TNF-alpha	Gene	7124
35620289	1587	1591	iNOS	Gene	51477
35620289	1623	1628	MMP-2	Gene	4313
35620289	1629	1634	MMP-9	Gene	4318
35620289	1643	1652	Microglia	Disease	
35620289	1702	1705	SWE	CellLine	CVCL:0019
35620289	1786	1798	inflammation	Disease	MESH:D007249
35620289	1872	1878	MAP2K6	Gene	5608
35620289	1906	1910	PAWR	Gene	5074
35620289	2003	2008	TGFB1	Gene	7040
35620289	2010	2014	PAWR	Gene	5074
35620289	2020	2026	EFEMP1	Gene	2202
35620289	2188	2197	microglia	Disease	
35620289	2238	2244	Dicer1	Gene	23405
35620289	2327	2330	SWE	CellLine	CVCL:0019
35620289	2430	2439	microglia	Disease	
35620289	2509	2518	microglia	Disease	
35620289	2607	2619	inflammation	Disease	MESH:D007249
35620289	2623	2625	AD	Disease	MESH:D000544
35620289	2637	2654	neurodegeneration	Disease	MESH:D019636
35620289	2760	2762	AD	Disease	MESH:D000544
35620289	2820	2827	patient	Species	9606
35620289	Association	3458	383
35620289	Positive_Correlation	3146	3458
35620289	Positive_Correlation	MESH:D007249	3458
35620289	Association	MESH:D007249	3553
35620289	Association	MESH:D007249	3146
35620289	Association	MESH:D007249	383
35620289	Positive_Correlation	3458	3553
35620289	Positive_Correlation	3458	51477
35620289	Association	MESH:D007249	3586
35620289	Association	MESH:D007249	51477
35620289	Association	3458	406909

